幽门螺杆菌感染与HBV感染相关肝病的关系

赵小诺; 马素平; 肖准

doi:10.12449/JCH250221

幽门螺杆菌感染与HBV感染相关肝病的关系

DOI: 10.12449/JCH250221

赵小诺¹,
马素平^2, , ,,
肖准²

1.
河南中医药大学第一临床医学院，郑州 450000
2.
河南中医药大学第一附属医院脾胃肝胆病科，郑州 450000

基金项目:

国家自然科学基金青年基金 (82104772);

河南省科技发展计划（科技攻关）项目 (222102310502);

河南省特色骨干学科中医学学科建设项目 (STG-ZYX02-202109);

河南省中医药科学研究专项 (2022ZY2008);

河南省科技研发计划联合基金 (222301420062)

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：赵小诺负责撰写修改文章；马素平、肖准负责拟定文章写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
马素平， masuping@163.com （ORCID： 0000-0002-5398-4424）

计量
- 文章访问数: 1805
- HTML全文浏览量: 61
- PDF下载量: 30
- 被引次数: 0
出版历程
- 收稿日期: 2024-06-25
- 录用日期: 2024-07-29
- 出版日期: 2025-02-25

Association between Helicobacter pylori infection and hepatitis B virus-related liver diseases

Xiaonuo ZHAO¹,
Suping MA^{2
, ,
,},
Zhun XIAO²

1.
The First Clinical Medical College of Henan University of Chinese Medicine，Zhengzhou 450000，China
2.
Department of Hepatology and Spleen-Stomach，The First Affiliated Hospital of Henan University of Chinese Medicine，Zhengzhou 450000，China

Research funding:

National Natural Science Foundation Youth Foundation (82104772);

The Project of Science and Technology Research in the Development Plan of Henan Province (222102310502);

Construction Project for Traditional Chinese Medicine in Henan Province (STG-ZYX02-202109);

Special Research Project of TCM in Henan Province (2022ZY2008);

Henan Province Science and Technology Research and Development Program Joint Fund (222301420062)

More Information

Corresponding author: MA Suping， masuping@163.com （ORCID： 0000-0002-5398-4424）

摘要

摘要: 慢性乙型肝炎作为我国常见传染病，是通过感染HBV引起机体的免疫应答而导致肝细胞损伤及炎症坏死。幽门螺杆菌‍（‍Hp）‍是一种革兰阴性螺杆菌，能够在人胃黏膜定植并持续生存。近年来，有关Hp感染与HBV感染相关肝病之间的密切联系被越来越多的研究所证实。本文通过回顾近年来有关Hp感染与HBV感染相关肝病的文献，对其相关性进行探讨，分析表明Hp感染与HBV感染相关肝病之间存在相关性。慢性乙型肝炎患者对Hp的易感性会随着乙型肝炎的疾病进展而增加。同时Hp感染也可能会增加乙型肝炎肝硬化患者出现食管等静脉曲张破裂出血的发生率、提高肝性脑病的发生风险。因此，在临床中，对于HBV感染相关肝病患者，应重视Hp感染的筛查与治疗。
- 乙型肝炎病毒 /
- 肝硬化 /
- 感染 /
- 幽门螺杆菌
Abstract: As a common infectious disease in China， chronic hepatitis B is hepatocyte injury and inflammatory necrosis due to immune response caused by hepatitis B virus （HBV）. Helicobacter pylori （Hp） is a Gram-negative helicobacter that colonizes and persists in the human gastric mucosa. In recent years， an increasing number of studies have confirmed the close association between Hp infection and HBV-related liver diseases. This article reviews the articles on Hp infection and HBV-related liver diseases in recent years and discusses the association between Hp infection and HBV-related liver diseases， which shows the association between Hp infection and HBV-related liver diseases. The susceptibility to Hp in chronic hepatitis B patients increases with the progression of hepatitis B， and at the same time， Hp infection may increase the incidence rate of esophageal variceal rupture and hemorrhage and the risk of hepatic encephalopathy in patients with hepatitis B cirrhosis. Therefore， the screening and treatment of Hp infection in patients with HBV-related liver diseases should be taken seriously in clinical practice.
- Hepatitis B Virus /
- Liver Cirrhosis /
- Infections /
- Helicobacter pylori

HTML全文

参考文献(45)

[1]	EUSEBI LH, ZAGARI RM, BAZZOLI F. Epidemiology of Helicobacter pylori infection[J]. Helicobacter, 2014, 19( Suppl 1): ‍ 1- 5.‍ DOI: ‍10.1111/hel.12165.
[2]	ORGANISATION WG. World gastroenterology organisation global guideline: Helicobacter pylori in developing countries[J]. J Clin Gastroenterol, 2011, 45( 5): 383- 388. DOI: 10.1097/MCG.0b013e31820fb8f6.
[3]	LIU ZB, TANG J, WU TT. Expression levels of serum COX-2 and TFF2 in patients with different oLGIM stages of chronic gastritis and their correlation with Helicobacterpylori infection[J]. J Clin Exp Med, 2023, 22( 24): 2596- 2600. DOI: 10.3969/j.issn.1671-4695.2023.24.006. 刘振北, 唐军, 吴婷婷. 不同OLGIM分期慢性胃炎患者血清COX-2、TFF2表达水平及其与幽门螺杆菌感染的相关性分析[J]. 临床和实验医学杂志, 2023, 22( 24): 2596- 2600. DOI: 10.3969/j.issn.1671-4695.2023.24.006.
[4]	LI MS, HAN ZB. High risk and controllable factor of gastric cancer--Helicobacter pylori infection[J/CD]. Chin J Exp Clin Infect Dis(Electronic Edition), 2023, 17( 3): 145- 150. DOI: 10.3877/cma.j.issn.1674-1358.2023.03.001. 李梦声, 韩中博. 胃癌的高危可控因素——幽门螺杆菌感染[J/CD]. 中华实验和临床感染病杂志(电子版), 2023, 17( 3): 145- 150. DOI: 10.3877/cma.j.issn.1674-1358.2023.03.001.
[5]	LI C. Explore the Prevalence of HpInfection in Patients with Liver Disease[D]. Yangzhou: Yangzhou University, 2011. 李翠. 乙肝病毒相关性肝病患者幽门螺旋杆菌感染的研究[D]. 扬州: 扬州大学, 2011.
[6]	LI M, XIN CS, PAN ZS, et al. Clinical analysis of Helicobacterpylori infection in patients with viral hepatitis B[J]. Chin J Clin Hepatol, 2006, 22( 2): 136- 137. DOI: 10.3969/j.issn.1001-5256.2006.02.026. 李梅, 辛崇尚, 潘兆随, 等. 乙型病毒性肝炎患者幽门螺杆菌感染的临床分析[J]. 临床肝胆病杂志, 2006, 22( 2): 136- 137. DOI: 10.3969/j.issn.1001-5256.2006.02.026.
[7]	JI SW, WANG JB, ZHANG YG. Helicobacter pylori seroprevalence in chronic hepatitis B patients[J]. Chin J Lab Diagn, 2008, 12( 4): 479- 481. DOI: 10.3969/j.issn.1007-4287.2008.04.021. 季尚玮, 王江滨, 张永贵. 慢性乙型肝炎患者幽门螺杆菌感染状况分析[J]. 中国实验诊断学, 2008, 12( 4): 479- 481. DOI: 10.3969/j.issn.1007-4287.2008.04.021.
[8]	CUI FQ, ZHUANG H. Interpretation of global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: Progress in elim inating viral hepatitis[J/CD]. Chin J Front Med Sci Electron Version, 2021, 13( 10): 1- 4. DOI: 10.12037/YXQY.2021.10-01. 崔富强, 庄辉. 解读《2021年艾滋病病毒、病毒性肝炎和性传播感染全球进展报告》: 消除病毒性肝炎进展[J/CD]. 中国医学前沿杂志(电子版), 2021, 13( 10): 1- 4. DOI: 10.12037/YXQY.2021.10-01.
[9]	COLLABORATORS PO. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: A modelling study[J]. Lancet Gastroenterol Hepatol, 2018, 3( 6): 383- 403. DOI: 10.1016/S2468-1253(18)30056-6.
[10]	PÉNEAU C, IMBEAUD S, BELLA TL, et al. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma[J]. Gut, 2022, 71( 3): 616- 626. DOI: 10.1136/gutjnl-2020-323153.
[11]	NGUYEN MH, WONG G, GANE E, et al. Hepatitis B virus: Advances in prevention, diagnosis, and therapy[J]. Clin Microbiol Rev, 2020, 33( 2): e00046-19. DOI: 10.1128/CMR.00046-19.
[12]	KAMALAPORN P, SOBHONSLIDSUK A, JATCHAVALA J, et al. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients[J]. ‍ Aliment ‍Pharmacol ‍Ther,‍ ‍ 2005,‍ ‍ 21( 12): ‍‍‍ 1459- 1465. ‍‍ DOI: ‍‍10.1111/j.1365-2036.2005.02507.x.
[13]	GOODWIN CS, ARMSTRONG JA, MARSHALL BJ. Campylobacter pyloridis, gastritis, and peptic ulceration[J]. J Clin Pathol, 1986, 39( 4): 353- 365. DOI: 10.1136/jcp.39.4.353.
[14]	WANG H, LIU ZY. Effect of Hp infection on gastrin and interleukin 1β in patients with gastric ulcer and its clinical significance[J]. J Logist Univ PAP Med Sci, 2021, 30( 7): 63- 65. DOI: 10.16548/j.2095-3720.2021.07.062. 汪泓, 刘兆云. Hp感染对胃溃疡患者胃泌素、白细胞介素1β的影响及其临床意义[J]. 武警后勤学院学报(医学版), 2021, 30( 7): 63- 65. DOI: 10.16548/j.2095-3720.2021.07.062.
[15]	HU CG. To study the infection status and characteristics of helicobacter pylori in patients with hepatitis B virus associated liver disease[J/CD]. World Latest Med Info, 2018, 18( 39): 79, 81. DOI: 10.19613/j.cnki.1671-3141.2018.39.052. 胡朝刚. 研究并探讨乙肝病毒相关性肝病患者幽门螺旋杆菌感染情况与特征[J/CD]. 世界最新医学信息文摘(连续型电子期刊), 2018, 18( 39): 79, 81. DOI: 10.19613/j.cnki.1671-3141.2018.39.052.
[16]	PIMENTEL-NUNES P, LIBÂNIO D, MARCOS-PINTO R, et al. Management of epithelial precancerous conditions and lesions in the stomach(MAPS II): European society of gastrointestinal endoscopy(ESGE), European Helicobacter and microbiota study group(EHMSG), European society of pathology(ESP), and sociedade portuguesa de endoscopia digestiva(SPED) guideline update 2019[J]. Endoscopy, 2019, 51( 4): 365- 388. DOI: 10.1055/a-0859-1883.
[17]	FAN XG, ZOU YY, WU AH, et al. Seroprevalence of Helicobacter pylori infection in patients with hepatitis B[J]. Br J Biomed Sci, 1998, 55( 3): 176- 178.
[18]	ZHAO B, SHENG QJ, QIN Y, et al. Correlations of Helicobacter pylori with liver function, inflammatory factors and serum levels of FoxP3 and RORγt in patients with hepatitis B cirrhosis[J]. Eur Rev Med Pharmacol Sci, 2021, 25( 1): 459- 465. DOI: 10.26355/eurrev_202101_24415.
[19]	TU C, YOU J, LIU HE, et al. Changes of Th17 and Treg and the expressions of RORγt and Foxp3 mRNA in patients with HBV related liver cirrhosis and the clinical significance[J]. Chin Gen Pract, 2016, 19( 18): 2130- 2134. 涂琛, 游晶, 刘怀鄂, 等. 乙型肝炎肝硬化患者辅助性T淋巴细胞17和调节性T淋巴细胞及维甲酸相关核孤儿受体γt和叉状头/翅膀状螺旋转录因子3 mRNA表达水平的变化及其临床意义研究[J]. 中国全科医学, 2016, 19( 18): 2130- 2134.
[20]	GAO HQ. Investigation and analysis of hepatitis B and related liver disease Hp infection[J]. Med Forum, 2015, 19( 21): 2921- 2922. 高宏琴. 乙型肝炎及相关肝病Hp感染的调查分析[J]. 基层医学论坛, 2015, 19( 21): 2921- 2922.
[21]	OKUSHIN K, TSUTSUMI T, IKEUCHI K, et al. Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis[J]. World J Gastroenterol, 2018, 24( 32): 3617- 3625. DOI: 10.3748/wjg.v24.i32.3617.
[22]	WANG J, CHEN RC, ZHENG YX, et al. Helicobacter pylori infection may increase the risk of progression of chronic hepatitis B disease among the Chinese population: A meta-analysis[J]. Int J Infect Dis, 2016, 50: 30- 37. DOI: 10.1016/j.ijid.2016.07.014.
[23]	CHEN Y, CHEN YY, HAN XY, et al. Correlation between Helicobacter pylori and hepatitis B virus and gastric mucosa lesions in hepatitis B patients[J]. Chin J Nosocomiology, 2016, 26( 14): 3184- 3186. DOI: 10.11816/cn.ni.2016-153797. 陈轶, 陈益耀, 韩向阳, 等. 幽门螺杆菌与乙型肝炎病毒对乙型病毒性肝炎患者胃黏膜病变的相关分析[J]. 中华医院感染学杂志, 2016, 26( 14): 3184- 3186. DOI: 10.11816/cn.ni.2016-153797.
[24]	CUI HX, JIN YZ, CHEN F, et al. Clinicopathological evidence of hepatitis B virus infection in the development of gastric adenocarcinoma[J]. J Med Virol, 2020, 92( 1): 71- 77. DOI: 10.1002/jmv.25584.
[25]	BAGHBANIAN M, HOSEINI MOUSA SA, DOOSTI M, et al. Association between gastric pathology and hepatitis B virus infection in patients with or without Helicobacter pylori[J]. Asian Pac J Cancer Prev, 2019, 20( 7): 2177- 2180. DOI: 10.31557/APJCP.2019.20.7.2177.
[26]	Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006. 中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35( 11): 2408- 2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
[27]	Chinese Society of Hepatology, Chinese Society of Gastroenterology, and Chinese Society of Digestive Endoscopology of Chinese Medical Association. Guidelines on the management of esophagogastric ‍variceal bleeding in cirrhotic portal hypertension[J]. J Clin Hepatol, 2023, 39( 3): 527- 538. DOI: 10.3969/j.issn.1001-5256.2023.03.znygf. 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会消化内镜学分会. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J]. 临床肝胆病杂志, 2023, 39( 3): 527- 538. DOI: 10.3969/j.issn.1001-5256.2023.03.znygf.
[28]	ZHAO GX, LIAN HM, YAN XN. Relationship between Helicobacter pylori infection and upper gastrointestinal hemorrhage and hepatic encephalopathy in patients with liver cirrhosis[J]. Hainan Med J, 2019, 30( 21): 2755- 2757. 赵改仙, 连红梅, 阎小宁. 幽门螺杆菌感染与肝硬化患者上消化道出血及肝性脑病的关系[J]. 海南医学, 2019, 30( 21): 2755- 2757.
[29]	ZHAO BH, ZHANG YH, DU HL, et al. Relationship between upper gastrointestinal hemorrhage, helicobacter pylori infection and liver function grading in patients with hepatitis B cirrhosis[J]. Clin J Med Off, 2023, 51( 7): 761- 764. DOI: 10.16680/j.1671-3826.2023.07.25. 赵宝海, 张咏华, 杜红蕾, 等. 乙型肝炎肝硬化患者上消化道出血与幽门螺旋杆菌感染、肝功能分级关系[J]. 临床军医杂志, 2023, 51( 7): 761- 764. DOI: 10.16680/j.1671-3826.2023.07.25.
[30]	ZHANG M, YANG LQ, CHEN JT, et al. Study on the correlation between liver cirrhosis complications and Helicobacter pylori infection[J]. Shaanxi Med J, 2017, 46( 12): 1664- 1665. DOI: 10.3969/j.issn.1000-7377.2017.12.017. 张鸣, 杨柳青, 陈建婷, 等. 肝硬化并发症与幽门螺杆菌感染的相关性研究[J]. 陕西医学杂志, 2017, 46( 12): 1664- 1665. DOI: 10.3969/j.issn.1000-7377.2017.12.017.
[31]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. J Clin Hepatol, 2018, 34( 10): 2076- 2089. DOI: 10.3969/j.issn.1001-5256.2018.10.007. 中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 临床肝胆病杂志, 2018, 34( 10): 2076- 2089. DOI: 10.3969/j.issn.1001-5256.2018.10.007.
[32]	ALDRIDGE DR, TRANAH EJ, SHAWCROSS DL. Pathogenesis of hepatic encephalopathy: Role of ammonia and systemic inflammation[J]. J Clin Exp Hepatol, 2015, 5( Suppl 1): S7- S20. DOI: 10.1016/j.jceh.2014.06.004.
[33]	WANG J, YANG B, DAI KK, et al. Clinical influence of Helicobacter pylori infection on peptic ulcer in patients with chronic hepatitis B and liver cirrhosis[J]. Chin J Nosocomiology, 2017, 27( 14): 3200- 3203. 王娟, 杨兵, 戴可可, 等. 幽门螺杆菌感染对慢性乙型肝炎及乙肝肝硬化患者消化道溃疡的临床影响[J]. 中华医院感染学杂志, 2017, 27( 14): 3200- 3203.
[34]	HOU YL, GAO MD, GUO HY, et al. Diagnostic value of albumin-bilirubin grade combined with serum ammonia in cirrhosis with hepatic encephalopathy[J]. Natl Med J China, 2018, 98( 2): 127- 131. DOI: 10.3760/cma.j.issn.0376-2491.2018.02.011. 侯玉丽, 高梦丹, 郭鸿雁, 等. 白蛋白-胆红素指数与血氨联合检测对肝硬化并发肝性脑病的诊断价值评估[J]. 中华医学杂志, 2018, 98( 2): 127- 131. DOI: 10.3760/cma.j.issn.0376-2491.2018.02.011.
[35]	GUO HH, PENG B, HU XQ, et al. Clinical observation on the relationship between the Helicobacter pylori infection and TNF-α-308 gene polymorphisms in patients with hepatitis B virus-related liver disease[J]. Chin J Clin Gastroenterol, 2020, 32( 1): 34- 37. 郭欢欢, 彭波, 胡小琴, 等. 幽门螺旋杆菌感染与肿瘤坏死因子-α-308多态性对乙肝相关性肝病患者转归的影响[J]. 临床消化病杂志, 2020, 32( 1): 34- 37.
[36]	National Health Commission of the People‍’‍s Republic of China. Standard for diagnosis and treatment of primary liver cancer(2024 edition)[J]. J Clin Hepatol, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508. 中华人民共和国国家卫生健康委员会. 原发性肝癌诊疗指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40( 5): 893- 918. DOI: 10.12449/JCH240508.
[37]	MADALA S, MACDOUGALL K, SURAPANENI BK, et al. Coinfection of Helicobacter pylori and hepatitis C virus in the development of hepatocellular carcinoma: A systematic review and meta-analysis[J]. J Clin Med Res, 2021, 13( 12): 530- 540. DOI: 10.14740/jocmr4637.
[38]	HUANG Y, FAN XG, WANG ZM, et al. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma[J]. J Clin Pathol, 2004, 57( 12): 1273- 1277. DOI: 10.1136/jcp.2004.018556.
[39]	SU LM, LIU ZW, WANG YG, et al. Clinical analysis of Helicobacter pylori infection in chronic hepatitis B patients[J]. Clin Res Pract, 2020, 5( 13): 29- 30. DOI: 10.19347/j.cnki.2096-1413.202013011. 苏连明, 刘志威, 王育光, 等. 慢性乙肝患者幽门螺杆菌感染的临床分析[J]. 临床医学研究与实践, 2020, 5( 13): 29- 30. DOI: 10.19347/j.cnki.2096-1413.202013011.
[40]	WANG L, XIAO J. Research progress on the relationship between Helicobacter pylori infection and primary hepatocellular carcinoma[J]. Chin J Integr Tradit West Med Dig, 2021, 29( 11): 833- 836. 王莉, 肖君. Hp感染与原发性肝癌的相关性研究进展[J]. 中国中西医结合消化杂志, 2021, 29( 11): 833- 836.
[41]	SIREGAR G, SARI DN, SUNGKAR T. Serum VEGF levels in Helicobacter pylori infection and correlation with Helicobacter pylori cagA and vacA genes[J]. Open Access Maced J Med Sci, 2017, 5( 2): 137- 141. DOI: 10.3889/oamjms.2017.031.
[42]	Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites in cirrhosis(2023 version)[J]. Chin J Hepatol, 2023, 31( 8): 813- 826. DOI: 10.3760/cma.j.cn501113-20230719-00011. 中华医学会肝病学分会. 肝硬化腹水诊疗指南(2023年版)[J]. 中华肝脏病杂志, 2023, 31( 8): 813- 826. DOI: 10.3760/cma.j.cn501113-20230719-00011.
[43]	AITHAL GP, PALANIYAPPAN N, CHINA L, et al. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2021, 70( 1): 9- 29. DOI: 10.1136/gutjnl-2020-321790.
[44]	HE CX, KONG FT, CHAI XK, et al. Effect of probiotic-assisted eradication of cagA⁺/vacA s1m1 Helicobacter pylori on intestinal flora[J]. Biomed Res Int, 2022, 2022: 8607671. DOI: 10.1155/2022/8607671.
[45]	CHEN HH. Clinical analysis of Helicobacter pylori infection in patients with chronic hepatitis B[J]. KANGYI, 2021( 5): 262. DOI: 10.12332/j.issn.2095-6525.2021.05.250. 陈海鹤. 慢性乙肝患者幽门螺杆菌感染的临床分析[J]. 康颐, 2021( 5): 262. DOI: 10.12332/j.issn.2095-6525.2021.05.250.